Culturally Adapted Motivational Interviewing With CBT and Mindfulness Based Relapse Prevention for Substance Use Disorder in Pakistan (CAMIAB)
Feasibility Study of Culturally Adapted Cognitive Behavioral Therapy Based Integrated Motivational Interviewing and Mindfulness Intervention for Substance Use Disorder in Pakistan (CAMIAB)
1 other identifier
interventional
260
1 country
1
Brief Summary
The study has both quantitative and qualitative components. The aim of study is to:
- 1.Culturally adapt and integrate the existing Motivational Interviewing with Cognitive Behavioral Therapy(MICBT) and Mindfulness based Relapse Prevention (MBRP) for people with Substance Use Disorder (SUD) in Pakistan
- 2.Test the feasibility and acceptability of the integrated intervention called CAMIAB ('CAMIAB' means success in Urdu) in a randomized control trial (RCT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 25, 2021
CompletedFirst Posted
Study publicly available on registry
May 13, 2021
CompletedStudy Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedSeptember 19, 2024
September 1, 2024
1.5 years
April 25, 2021
September 3, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Feasibility measures
Feasibility will be determined by recruitment rates, adherence rate and retention rates. The criterion for success of feasibility is to recruit \>50% of eligible participants, adherence rate (number of home assignments completed; \> 50%) and retention rate of 70%.
From baseline to 3rd month (at the end of intervention)
Acceptability measure
Acceptability will be determined based on the number of sessions attended by participants and success criterion for intervention acceptability is mean attendance rate of at least 8 sessions.
From baseline to 3rd month (at the end of intervention)
Secondary Outcomes (4)
The Maudsley Addiction Profile
Change in problem scores from Baseline to 3rd Month and 6th month
The Short Warwick-Edinburgh Mental Well-being Scale
Change in scores from baseline to 3rd Month and 6th month
EuroQol-5
Change in scores from baseline to 3rd Month and 6th month
Client service receipt inventory
Changes from baseline to 3rd Month and 6th month
Study Arms (4)
Motivational Interviewing with CBT (MICBT)
EXPERIMENTALParticipants in this arm will receive a total of 12 weekly sessions of CBT based Motivational Interviewing over a period of 12 weeks.
Mindfulness based Relapse Prevention Group (MBRP)
EXPERIMENTALParticipants in this arm will receive a total of 12 weekly sessions of mindfulness intervention over a period of 12 weeks.
Integrated MICBT and MBRP Group (CAMIAB)
EXPERIMENTALThis will be integrated MICBT plus MBRP intervention. Participants will receive a total of 12 weekly sessions of this integrated CAMIAB intervention.
Treatment as usual (TAU)
NO INTERVENTIONThis will be routine care psychological treatment that they will be receiving.
Interventions
The culturally adapted MICBT will include approaches of motivational interviewing and offer ways of managing difficulties from a cognitive behavioural formulation.
MBRP will incorporate cognitive-behavioural skills (i.e., effective coping skills, self-efficacy, and recognizing common antecedents of relapse) with mindfulness-based practices to decrease the probability of relapse by increasing awareness and flexible responding in the presence of substance use triggers.
This will be integrated CBT based motivational interviewing plus mindfulness based relapse prevention intervention group.
Eligibility Criteria
You may qualify if:
- Participants with substance use disorder
- Meeting DSM-V criteria for substance use disorder
- Age 18 years and above
- Being able to understand spoken or written Urdu
- Have undergone through the process of detoxification before study intervention
You may not qualify if:
- Any evidence of organic brain disease, clinically significant cooccurring medical illness or mental illness to the extent that can impede their ability to provide informed consent or engagement in the intervention.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pakistan Recovery Oasis
Lahore, Pakistan
Related Publications (1)
Asif M, Khoso AB, Husain MA, Shahzad S, Van Hout MC, Rafiq NU, Lane S, Chaudhry IB, Husain N. Culturally adapted motivational interviewing with cognitive behavior therapy and mindfulness-based relapse prevention for substance use disorder in Pakistan (CAMAIB): protocol for a feasibility factorial randomised controlled trial. Pilot Feasibility Stud. 2023 Apr 24;9(1):67. doi: 10.1186/s40814-023-01296-0.
PMID: 37095571DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Imran Bashir Chaudhry, Prof.
Pakistan Institute of Living and Learning
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 25, 2021
First Posted
May 13, 2021
Study Start
December 1, 2023
Primary Completion
June 1, 2025
Study Completion
June 1, 2025
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share